Source: International Congress 2019 – Clinical problems
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Bachouch (Ariana, Tunisia), N. Belloumi (Ariana, Tunisia), A. Slim (Ariana, Tunisia), S. Jrad (Ariana, Tunisia), A. Taboubi (Ariana, Tunisia), F. Chermiti (Ariana, Tunisia), S. Fenniche (Ariana, Tunisia). Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries.. 630

Member's Comments

No comment yet.

Related content which might interest you: Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006 Assessing response to treatment of exacerbations of bronchiectasis in adults Source: Eur Respir J 2009; 33: 312-318 Year: 2009 Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Factors associated with length of stay of hospitalised exacerbations for non-cystic fibrosis bronchiectasis Source: International Congress 2019 – Bronchiectasis Year: 2019 Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis. Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017 Year: 2018 Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe Source: ERJ Open Res, 7 (4) 00411-2021; 10.1183/23120541.00411-2021 Year: 2021 DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Exercise capacity can predict exacerbations and hospitalizations in a 1-year follow up in non-cystic fibrosis bronchiectasis adults Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018 Identifying undiagnosed cystic fibrosis in adults with bronchiectasis Source: Eur Respir Monogr 2018; 81: 29-44 Year: 2018 Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016 Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Frequency and pathogenicity of rhinovirus associated pulmonary exacerbations in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Non-cystic fibrosis bronchiectasis: etiology and predictors of exacerbations and mortality in patients across the largest health system in central and western Massachusetts Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017